Skip to content

Roivant Sciences ROIV Ratios & Valuation

TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25TTM Q4 '24
Efficiency
Asset turnover0.0×0.0×0.0×0.0×0.0×
Liquidity
Current ratio123.3×+13.6×138.4×+36.9×145.6×+54.3×122.3×+35.6×109.7×+44.5×
Leverage
Debt-to-equity0.1×0.0×0.1×-0.1×0.1×-0.2×0.1×-0.7×0.1×-1.1×
Per Share
Book value per share$25.45-7.8%$25.38-10.4%$26.44-6.8%$27.04+19.7%$27.60+64.1%
Valuation
Market capitalization$53.09B+65.5%$40.47B+21.4%$33.99B+0.8%$32.15B-6.1%$32.08B-6.2%
Price / sales4,379.9×+3,406×2,227.6×+1,332×1,376×+542×1,097×+280×974.1×+220×
Price / book12.1×+5.8×9.2×+3.1×7.4×+1.4×6.6×-7.2×6.3×-14.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Roivant Sciences's ratios come from?
Every ratio is computed from Roivant Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.